Details of the Drug
General Information of Drug (ID: DMKRHQ3)
Drug Name |
4-methyl-2H-benzofuro[3,2-g]chromen-2-one
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL201777; 105290-13-9; 2H-Benzofuro(3,2-g)-1-benzopyran-2-one, 4-methyl-; 4-Methyl-(1)benzofuro(3,2-g)chromen-2-one; 2H-Benzofuro[3,2-g]-1-benzopyran-2-one, 4-methyl-; 4-methyl-[1]benzofuro[3,2-g]chromen-2-one; 4-methyl-2H-benzofuro[3,2-g]chromen-2-one; ACMC-20c6p3; AC1Q6A2V; AC1L4EY2; 4-methyl-2h-[1]benzofuro[3,2-g]chromen-2-one; CTK0G5617; DTXSID00147060; ZINC6069630; BDBM50181850
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 250.25 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||